1. Skyler J: Diabetic complications: the importance of glucose control. Endocrinol Metab Clin North Am 1996, 25(2):243–245.

2. Giardino J, Brownlee M: Mechanisms of chronic diabetic complications. In Textbook of Diabetes, vol 1. Edited by Pickup JC, Williams G. London: Blackwell Scientific; 1997.

3. Kaiser N, Sasson S, Feener EP: Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes 1993, 42:80–89.

4. Giardino I, Edelstein D, Brownlee M: BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 1996, 97:1422–1428.

5. Chandra A, Srivastava S, Petrash JM:Active site modification of aldose reductase by nitric oxide donors. Biochim Biophys Acta 1997, 131:217–222.

6. Pieper GM, Langenstroer P, Siebeneich W: Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997, 34:145–156.

7. King GL, Brownlee MB:The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am 1996, 25(2):255–270.

8. Engerman RL, Kern TS, Larson ME: Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia 1994, 37:141–144.

9. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 1998, 47:859–867.

10. Taher MM, Garcia JG, Natarajian V: Hydroperoxide-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch Biochem Biophys 1993, 303:260–266.

11. Schuppe-Koistinen I, Modιus P, Bergman T, Cotgreave IA: S-thiolation of human endothelial cell glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem 1994, 221:1033–1037.

12. Ishii H, Jirousek MR, Koya D, et al.: Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 1996, 272:728–731.

13. Shinohara M,Thornalley PJ, Giardino I, et al.: Overexpression of glyoxalase- I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 1998, 101(5): 1142–1147.

14. Vander Jagt DL,Torres JE, Hunsaker LA, et al.: Physiological substrates of human aldose and aldehyde reductases. Adv Exp Med Biol 1997, 414:491–497.

15. Brownlee M: Glycation and diabetic complications. Diabetes 1994, 43:836–841.

16. Cochrane SM, Robinson GB: In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications. FEBS Lett 1995, 375:41–44.

17. Yan SD, Schmidt AM, Anderson GM, et al.: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994, 269:9889–9897.

18. Li YM, Mitsuhashi T, Wojciechowicz D, et al.: Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc Natl Acad Sci U S A 1996, 93:11047–11052.

19. Vlassara H, Li YM, Imani F, et al.: Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1995, 1:634–646.

20. Araki N, Higashi T, Mori T, et al.: Macrophage scavenger receptor mediates the endocytic uptake and degradation of advanced glycation end products of the Maillard reaction. Eur J Biochem 1995, 230:408–415.

21. Brownlee M:Advanced glycation end products in diabetic complications. Curr Opin Endocrinol Diabetes 1998, 3:291–297.

22. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813–820.

23. Gray RP, Yudkin JS: Cardiovascular disease in diabetic mellitus. In Textbook of Diabetes, vol. 1. Edited by Pickup JC, Williams G. London: Blackwell Scientific; 1997.

24. Krolewski SA,Warram JH, Freire MB, et al.: Epidemiology of late diabetic complications: a basis for the development and evaluation of prevention programs. Endocrinol Metab Clin North Am 1996, 25(2):217–242.

25. Trevisan R, Barnes DJ, et al.: Pathogenesis of diabetic nephropathy. In Textbook of Diabetes, vol. 2. Edited by Pickup JC, Williams G. London: Blackwell Scientific; 1997.

26. Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987, 36:808–812.

27. Wei Y: Oxidative stress and mitochondrial DNA mutations in human aging. Soc Exp Biol Med 1998, 217:53–63.

28. Nishikawa T, Edelstein D, Brownlee MB, et al.: Reversal of hyperglycemia-induced PKC activation, intracellular AGE formation, and sorbitol accumulation by inhibition of electron transport complex II. Diabetes 1999, 48(Suppl):A73.